These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18977391)

  • 1. Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS).
    Serafini S; Fraternale A; Rossi L; Casabianca A; Antonelli A; Paoletti MF; Orlandi C; Pierigè F; Sfara C; Schiavano GF; Magnani M
    Antiviral Res; 2009 Feb; 81(2):93-102. PubMed ID: 18977391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of macrophage protection in the development of murine AIDS.
    Fraternale A; Tonelli A; Casabianca A; Vallanti G; Chiarantini L; Schiavano GF; Benatti U; De Flora A; Magnani M
    J Acquir Immune Defic Syndr; 1999 Jun; 21(2):81-9. PubMed ID: 10360798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model.
    Fraternale A; Casabianca A; Orlandi C; Cerasi A; Chiarantini L; Brandi G; Magnani M
    Antiviral Res; 2002 Dec; 56(3):263-72. PubMed ID: 12406509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of defective and ecotropic viruses during LP-BM5 infection by real time PCR and RT-PCR.
    Paun A; Shaw K; Fisher S; Sammels LM; Watson MW; Beilharz MW
    J Virol Methods; 2005 Mar; 124(1-2):57-63. PubMed ID: 15664051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selenium supplementation on mice infected with LP-BM5 MuLV, a murine AIDS model.
    Chen C; Zhou J; Xu H; Jiang Y; Zhu G
    Biol Trace Elem Res; 1997; 59(1-3):187-93. PubMed ID: 9522061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated cycles of alternate administration of fludarabine and Zidovudine plus Didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels.
    Fraternale A; Casabianca A; Orlandi C; Chiarantini L; Brandi G; Silvestri G; Magnani M
    Virology; 2002 Oct; 302(2):354-62. PubMed ID: 12441079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of murine AIDS by a new azidothymidine homodinucleotide.
    Magnani M; Casabianca A; Fraternale A; Brandi G; Chiarantini L; Benatti U; Scarfì S; Millo E; De Flora A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):189-95. PubMed ID: 9495216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective use of ribonucleotide reductase inhibitors (Didox and Trimidox) alone or in combination with didanosine (ddI) to suppress disease progression and increase survival in murine acquired immunodeficiency syndrome (MAIDS).
    Mayhew C; Oakley O; Piper J; Hughes NK; Phillips J; Birch NJ; Elford HL; Gallicchio VS
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1019-29. PubMed ID: 9449534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of murine AIDS (MAIDS) development in C57BL/6J mice by tyrphostin AG-1387.
    Sklan EH; Gazit A; Priel E
    Virology; 2000 Dec; 278(1):95-102. PubMed ID: 11112485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of murine AIDS by alternate administration of azidothymidine and fludarabine monophosphate.
    Fraternale A; Casabianca A; Tonelli A; Vallanti G; Chiarantini L; Brandi G; Celeste AG; Magnani M
    J Acquir Immune Defic Syndr; 2000 Mar; 23(3):209-20. PubMed ID: 10839656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS.
    Fraternale A; Tonelli A; Casabianca A; Chiarantini L; Schiavano GF; Celeste AG; Magnani M
    J Acquir Immune Defic Syndr; 2000 Feb; 23(2):107-13. PubMed ID: 10737424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged islet allograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes.
    Rossi L; Migliavacca B; Pierigé F; Serafini S; Sanvito F; Olivieri S; Nano R; Antonioli B; Magnani M; Bertuzzi F
    Transplantation; 2008 Feb; 85(4):648-50. PubMed ID: 18347547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of murine AIDS by pro-glutathione (GSH) molecules.
    Fraternale A; Paoletti MF; Casabianca A; Orlandi C; Schiavano GF; Chiarantini L; Clayette P; Oiry J; Vogel JU; Cinatl J; Magnani M
    Antiviral Res; 2008 Feb; 77(2):120-7. PubMed ID: 18164447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
    Mayhew CN; Sumpter R; Inayat M; Cibull M; Phillips JD; Elford HL; Gallicchio VS
    Antiviral Res; 2005 Jan; 65(1):13-22. PubMed ID: 15652967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drug combinations for the treatment of murine AIDS and macrophage protection.
    Fraternale A; Casabianca A; Tonelli A; Chiarantini L; Brandi G; Magnani M
    Eur J Clin Invest; 2001 Mar; 31(3):248-52. PubMed ID: 11264653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IP-10/CXCL10 in the progression of pancreatitis-like injury in mice after murine retroviral infection.
    Kawauchi Y; Suzuki K; Watanabe S; Yamagiwa S; Yoneyama H; Han GD; Palaniyandi SS; Veeraveedu PT; Watanabe K; Kawachi H; Okada Y; Shimizu F; Asakura H; Aoyagi Y; Narumi S
    Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G345-54. PubMed ID: 16825661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a real-time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS.
    Casabianca A; Orlandi C; Fraternale A; Magnani M
    J Clin Microbiol; 2004 Sep; 42(9):4361-4. PubMed ID: 15365045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate.
    Fraternale A; Casabianca A; Rossi L; Chiarantini L; Brandi G; Aluigi G; Schiavano GF; Magnani M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):164-73. PubMed ID: 8680888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentoxifylline and meclofenamic acid treatment reduces clinical manifestations in a murine model of AIDS.
    Stadler I; Chadha KC; Nakeeb S; Toumbis C; Butsch J; Mathur N; Munschauer F; Vladutiu A; Satchidanand SK; Ambrus JL
    J Pharmacol Exp Ther; 1994 Jan; 268(1):10-3. PubMed ID: 8301544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZDV delays but does not prevent the transmission of MAIDS by LP-BM5 MuLV-infected macrophage-monocytes.
    Bilello JA; Kort JJ; MacAuley C; Fredrickson TN; Yetter RA; Eiseman JL
    J Acquir Immune Defic Syndr (1988); 1992; 5(6):571-6. PubMed ID: 1316959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.